Healthcare Sector

BMY

Market Tracker

$46.72
-0.91
(-1.91%)
5:33 pm
Next Earnings: (est.) 07/27/23 12:00 am
  • BMY (Selected)

    Bristol-Myers Squibb Company

BMY Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

BMY Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

BMY Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

BMY Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

BMY Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

BMY Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
08/29/2025 CALL $48.00 3,239 +2,003 +162.06%
10/17/2025 CALL $52.50 3,607 +1,456 +67.69%
09/05/2025 CALL $49.00 2,853 +655 +29.80%
10/17/2025 CALL $49.00 1,343 +641 +91.31%
11/21/2025 CALL $50.00 5,008 +214 +4.46%
09/19/2025 CALL $44.00 705 +189 +36.63%
08/29/2025 PUT $50.00 7 -29 -80.56%
11/21/2025 PUT $45.00 3,327 -32 -0.95%
09/12/2025 PUT $47.00 138 -40 -22.47%
11/21/2025 PUT $40.00 4,524 -42 -0.92%
01/16/2026 CALL $43.00 7,059 -49 -0.69%
12/19/2025 CALL $57.50 1,922 -200 -9.43%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

BMY Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.07% 64.63M 4.03B
Vanguard 500 Index Fund 2.34% 49.15M 3.06B
Fidelity 500 Index Fund 1.11% 23.31M 1.45B
SPDR S&P 500 ETF Trust 1.09% 23.02M 1.43B
iShares Core S&P 500 ETF 0.90% 18.98M 1.18B
Vanguard Index-Value Index Fund 0.87% 18.37M 1.14B
JP Morgan Equity Income Fund 0.82% 17.35M 1.08B
Select Sector SPDR Fund-Health Care 0.82% 17.27M 1.08B
American Mutual Fund Inc 0.78% 16.49M 1.03B
Vanguard Institutional Index Fund-Institutional Index Fund 0.71% 14.9M 927.91M

BMY News

  • Hodgkin’s Lymphoma Market Set to Reach New Heights by 2034 with Innovative Therapies and Clinical Successes | DelveInsight

    08/28 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Scenic Enters License and Research Agreement with Alnylam

    08/26 05:00 am

    GlobeNewswire Inc.

    Read more
  • Anal Cancer Market Size to Reach USD 2.08 Billion by 2032, Fueled by Rising HPV-Linked Cases and Advancements in Targeted Therapies – SNS Insider

    08/22 10:00 am

    GlobeNewswire Inc.

    Read more
  • Questex’s Fierce Pharma Week Announces Star-Studded Lineup with Jamie-Lynn Sigler, James Van Der Beek, Selma Blair, Kelly Killoran Bensimon and John Duffield to Provide Powerful Stories of Resilience and Healing

    08/20 10:00 am

    GlobeNewswire Inc.

    Read more
  • PD-(L)1 Inhibitors Market Set to Surge During the Forecast Period (2025–2034) as Immuno-Oncology Therapies Gain Momentum | DelveInsight

    08/18 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Want Over $2,100 in Annual Dividends? Invest $12,000 Into Each of These 3 High-Yielding Stocks

    08/13 06:26 am

    The Motley Fool

    Read more
  • CytomX (CTMX) Q2 Revenue Drops 26%

    08/07 06:29 pm

    The Motley Fool

    Read more
  • PRME Revenue Misses by 73%

    08/07 12:27 pm

    The Motley Fool

    Read more
  • Global Myeloproliferative Disorder Treatment Market is Expected to Showcase an Incremental Growth at a CAGR of ~5% by 2032 | DelveInsight

    08/06 01:00 pm

    GlobeNewswire Inc.

    Read more
  • BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

    08/04 10:32 am

    Benzinga

    Read more
  • Altanine Names Charles J. Andres, Ph.D., J.D., as CEO to Lead Clinical and Strategic Expansion

    07/29 10:00 am

    GlobeNewswire Inc.

    Read more
  • Oncology Drugs Market Insights, Competitive Landscape, and Forecast Report 2025-2032 | Immunotherapy Leads Growth in Oncology Market Due to Better Precision and Fewer Side Effects

    07/25 10:50 am

    GlobeNewswire Inc.

    Read more
  • Rheumatologists Eye AbbVie’s Rinvoq, Roche/Genentech’s Gazyva, and Bristol Myers Squibb’s Sotyktu as Front-Runners to Address Persistent Gaps in Systemic Lupus Erythematosus Care, Spherix Global Insights Reports

    07/23 12:51 pm

    GlobeNewswire Inc.

    Read more
  • Melanoma Market Anticipates a Dynamic Shift During the Forecast Period (2025–2034) Owing to the Strong Pipeline Activity | DelveInsight

    07/22 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Bristol Myers' Drug Flunks Blood Cancer-Associated Anemia Trial

    07/18 01:54 pm

    Benzinga

    Read more
  • As Excitement Builds for HR Tech 2025, HR Executive Reveals Finalists of HR Icons Awards

    07/16 07:00 am

    GlobeNewswire Inc.

    Read more
  • 3 Reasons the Schwab U.S. Dividend Equity ETF Is an Attractive Investment for Retirees

    07/16 04:25 am

    The Motley Fool

    Read more
  • FDA Eases Rules For Bristol Myers' Cell Therapies For Blood Cancers

    06/27 11:34 am

    Benzinga

    Read more
  • 2 Beaten-Down Stocks to Avoid

    06/27 08:15 am

    The Motley Fool

    Read more
  • Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight

    06/24 01:00 pm

    GlobeNewswire Inc.

    Read more
  • ICPO Foundation ist Co-Founder der RLT Angels Association mit dem Ziel, den Zugang zur Radiotheranostik für eine Million PatientInnen auszubauen

    06/21 06:20 am

    GlobeNewswire Inc.

    Read more
  • ICPO Foundation co-founded the RLT Angels Association with the aim of growing access to Radiotheranostics to one million patients

    06/21 06:20 am

    GlobeNewswire Inc.

    Read more
  • Editas Medicine Is Great. Here's Why You Shouldn't Buy It.

    06/17 10:07 am

    The Motley Fool

    Read more
  • 2 Beaten-Down Dividend Stocks to Buy Right Now

    06/16 04:25 am

    The Motley Fool

    Read more
  • Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties

    06/10 05:55 pm

    GlobeNewswire Inc.

    Read more
  • Rheumatoid Arthritis Global Market Research Report 2025-2035: TNF Inhibitors, IL-6 Inhibitors, and JAK Inhibitors at the Forefront of Developing Biologic Therapies

    06/10 04:53 am

    GlobeNewswire Inc.

    Read more
  • Dilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsight

    06/05 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Epigenetics Market Anticipated to Achieve 11.8% CAGR

    06/03 01:31 pm

    GlobeNewswire Inc.

    Read more
  • Bristol Myers Inks $11 Billion Licensing Pact With BioNTech For Bispecific Cancer Drug

    06/02 10:14 am

    Benzinga

    Read more
  • Bispecific Antibody Drug Conjugates Clinical Trials Bispecific ADC Market Size Insight

    05/29 01:16 pm

    GlobeNewswire Inc.

    Read more
  • Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors

    05/27 09:00 am

    GlobeNewswire Inc.

    Read more
  • GlycoEra AG Raises $130 Million to Advance Novel Pipeline of Extracellular Protein Degraders for the Treatment of Autoimmune Diseases

    05/27 07:00 am

    GlobeNewswire Inc.

    Read more
  • Tubulis Achieves Key Milestone in BMS Strategic License Agreement as First Collaboration Tubutecan ADC Enters the Clinic

    05/20 05:00 am

    GlobeNewswire Inc.

    Read more
  • Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight

    05/12 01:00 pm

    GlobeNewswire Inc.

    Read more
  • U.S. Small Business Association Awards Renaissance Global Services Two Prestigious Honors

    05/09 07:00 am

    GlobeNewswire Inc.

    Read more
  • FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight

    05/06 03:21 pm

    Benzinga

    Read more
  • FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months

    05/02 03:37 pm

    Benzinga

    Read more
  • This High-Yield Pharma Stock Looks Like an Incredible Bargain

    04/30 06:45 am

    The Motley Fool

    Read more
  • Analysis of Cancer Immunotherapy Technologies and Global Markets to 2029 - Merck, Roche, Bristol-Myers Squibb Company, Johnson & Johnson Services, and AstraZeneca Dominate

    04/30 04:56 am

    GlobeNewswire Inc.

    Read more
  • 4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off

    04/26 06:05 pm

    The Motley Fool

    Read more
  • Bristol Myers Delivers Upbeat 2025 Forecast Despite China Tariffs Impact

    04/24 11:55 am

    Benzinga

    Read more
  • Thermo Fisher Beats Q1 Estimates, Lowers Full-Year Forecast As Tariffs And Costs Take A Toll

    04/23 04:49 pm

    Benzinga

    Read more
  • Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight-Loss Pill?

    04/15 07:39 am

    The Motley Fool

    Read more
  • These Large-Cap Stocks With China And EU Exposure Got Crushed In The One Of The Most Volatile Trading Week (Apr 7-Apr 11): Are These In Your Portfolio?

    04/13 11:33 am

    Benzinga

    Read more
  • Specialists Set Sights on CLE Pipeline as Unmet Needs Persist and Candidate Pool Expands, According to Spherix Global Insights

    04/10 01:58 pm

    GlobeNewswire Inc.

    Read more
  • Biopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline

    04/10 05:59 am

    GlobeNewswire Inc.

    Read more
  • Is Vertex Pharmaceuticals Stock a Buy?

    04/08 09:45 am

    The Motley Fool

    Read more
  • Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide

    04/08 04:48 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: